Post Chikungunya Chronic Arthritis: Systemic Inflammatory Status Triggering Acute Coronary Syndrome

Author(s): Dhruvkumar M. Patel, Mukundkumar V. Patel*, Kamal H. Sharma, Greshaben R. Patel, Manish B. Patel, Vipul V. Shah.

Journal Name: Current Rheumatology Reviews

Volume 15 , Issue 3 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Atherosclerosis, inflammation and coronary plaque destabilization are linked to each other. Infections due to various microbes may trigger Acute Coronary Syndrome (ACS) by systemic inflammation cascade.

Methods: We have evaluated the prevalence of Post Chikungunya Chronic Arthritis (PCCA) among 400 consecutive ACS patients (Case group) and compared with control group subjected to elective surgery by the prospective case-control observational study. Cases were excluded if standard criteria of ACS were not satisfied and in the control group if the patient suffered a Myocardial Infarction (MI) within 28 days of elective surgery. PCCA duration more than two years or serum IgM anti-CCP positive patients were also excluded from the case as well as a control group.

Results: The case and control groups were similar except, less number of heart failure (O.R.7.3, 95% C.I. 3.3-15.9) and chronic kidney injury patients (O.R. 0.5, 95% C.I. 0.3-0.9) in the elective surgery (control) group. PCCA was present in 24 out of 400 ACS cases and 8 out of 400 control group. Among ACS case-patients, those suffering from PCCA tended to be younger and more often women, with more diabetes, hypertension, chronic kidney injury and high mean CRP. In unadjusted analysis PCCA was three times more common in the case versus control (O.R. 3.0, 95% C.I. 1.4- 6.4); results were indistinguishable after multidiscipline adjustment (O.R. 3.0, 95% C.I. 1.3-6.8).

Conclusion: PCCA is common among patients with ACS and post-infective systemic inflammation of PCCA may trigger plaque destabilization.

Keywords: Chikungunya, acute coronary syndrome, post chikungunya chronic arthritis, systemic inflammation, post infective inflammation, inflammatory markers, atherosclerosis.

[1]
Narsimulu G, Prabhu N. Post-chikungunya chronic arthritis. J Assoc Physicians India 2011; 59: 81.
[PMID: 21751640]
[2]
Javelle E, Ribera A, Degasne I, Gaüzère B-A, Marimoutou C, Simon F. Specific management of post-chikungunya rheumatic disorders: a retrospective study of 159 cases in Reunion Island from 2006-2012. PLoS Negl Trop Dis 2015; 9(3)e0003603
[http://dx.doi.org/10.1371/journal.pntd.0003603] [PMID: 25760632]
[3]
Ng LFP, Chow A, Sun Y-J, et al. IL-1β, IL-6, and RANTES as biomarkers of Chikungunya severity. PLoS One 2009; 4(1)e4261
[http://dx.doi.org/10.1371/journal.pone.0004261] [PMID: 19156204]
[4]
Marx N, Neumann FJ, Ott I, et al. Induction of cytokine expression in leukocytes in acute myocardial infarction. J Am Coll Cardiol 1997; 30(1): 165-70.
[http://dx.doi.org/10.1016/S0735-1097(97)00116-2] [PMID: 9207638]
[5]
Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999; 340(2): 115-26.
[http://dx.doi.org/10.1056/NEJM199901143400207] [PMID: 9887164]
[6]
Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001; 104(3): 365-72.
[http://dx.doi.org/10.1161/01.CIR.104.3.365] [PMID: 11457759]
[7]
Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996; 312(7038): 1061-5.
[http://dx.doi.org/10.1136/bmj.312.7038.1061] [PMID: 8616412]
[8]
Neumann FJ, Ott I, Marx N, et al. Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arterioscler Thromb Vasc Biol 1997; 17(12): 3399-405.
[http://dx.doi.org/10.1161/01.ATV.17.12.3399] [PMID: 9437185]
[9]
Neumann FJ, Ott I, Gawaz M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995; 92(4): 748-55.
[http://dx.doi.org/10.1161/01.CIR.92.4.748] [PMID: 7543831]
[10]
Muhlestein JB, Anderson JL, Hammond EH, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998; 97(7): 633-6.
[http://dx.doi.org/10.1161/01.CIR.97.7.633] [PMID: 9495296]
[11]
Danesh J, Wong Y, Ward M, Muir J. Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: population based study of coronary heart disease. Heart 1999; 81(3): 245-7.
[http://dx.doi.org/10.1136/hrt.81.3.245] [PMID: 10026344]
[12]
Gattone M, Iacoviello L, Colombo M, et al. Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age. Am Heart J 2001; 142(4): 633-40.
[http://dx.doi.org/10.1067/mhj.2001.118118] [PMID: 11579353]
[13]
Higuchi ML, Sambiase N, Palomino S, et al. Detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured atherosclerotic plaques. Braz J Med Biol Res 2000; 33(9): 1023-6.
[http://dx.doi.org/10.1590/S0100-879X2000000900005] [PMID: 10973132]
[14]
Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105(9): 1135-43.
[http://dx.doi.org/10.1161/hc0902.104353] [PMID: 11877368]
[15]
Bainton D, Jones GR, Hole D. Influenza and ischaemic heart disease--a possible trigger for acute myocardial infarction? Int J Epidemiol 1978; 7(3): 231-9.
[http://dx.doi.org/10.1093/ije/7.3.231] [PMID: 721358]
[16]
Alber DG, Powell KL, Vallance P, Goodwin DA, Grahame-Clarke C. Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse. Circulation 2000; 102(7): 779-85.
[http://dx.doi.org/10.1161/01.CIR.102.7.779] [PMID: 10942747]
[17]
Mattila KJ. Viral and bacterial infections in patients with acute myocardial infarction. J Intern Med 1989; 225(5): 293-6.
[http://dx.doi.org/10.1111/j.1365-2796.1989.tb00084.x] [PMID: 2732669]
[18]
Cathcart ES, Spodick DH. Rheumatoid heart disease. A study of the incidence and nature of cardiac lesions in rheumatoid arthritis. N Engl J Med 1962; 266: 959-64.
[http://dx.doi.org/10.1056/NEJM196205102661901] [PMID: 13877345]
[19]
Karten I. Arteritis, myocardial infarction, and rheumatoid arthritis. JAMA 1969; 210(9): 1717-20.
[http://dx.doi.org/10.1001/jama.1969.03160350029004] [PMID: 5394665]
[20]
Tsakraklides VG, Blieden LC, Edwards JE. Coronary atherosclerosis and myocardial infarction associated with systemic lupus erythematosus. Am Heart J 1974; 87(5): 637-41.
[http://dx.doi.org/10.1016/0002-8703(74)90504-3] [PMID: 4818708]
[21]
Osler W. Lectures on angina pectoris and allied states (1897).William Osler’s Collected Papers on the Cardiovascular System. New York: Adams LB 1985; 239-57.
[22]
Collins S. Mortality from causes other than influenza and pneumonia during influenza epidemics. Public Health Rep 1932; 47: 2159-79.
[http://dx.doi.org/10.2307/4580606]
[23]
Spencer FA, Goldberg RJ, Becker RC, Gore JM. Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial Infarction. J Am Coll Cardiol 1998; 31(6): 1226-33.
[http://dx.doi.org/10.1016/S0735-1097(98)00098-9] [PMID: 9581712]
[24]
Enquselassie F, Dobson AJ, Alexander HM, Steele PL. Seasons, temperature and coronary disease. Int J Epidemiol 1993; 22(4): 632-6.
[http://dx.doi.org/10.1093/ije/22.4.632] [PMID: 8225736]
[25]
Siscovick DS, Raghunathan TE, Lin D, et al. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol 2000; 152(7): 674-7.
[http://dx.doi.org/10.1093/aje/152.7.674] [PMID: 11032163]
[26]
Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000; 102(25): 3039-45.
[http://dx.doi.org/10.1161/01.CIR.102.25.3039] [PMID: 11120692]
[27]
Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003; 348(14): 1322-32.
[http://dx.doi.org/10.1056/NEJMoa025028] [PMID: 12672859]
[28]
Ridker PM, Hennekens CH, Stampfer MJ, Wang F. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation 1998; 98(25): 2796-9.
[http://dx.doi.org/10.1161/01.CIR.98.25.2796] [PMID: 9860778]
[29]
Meier CR, Jick SS, Derby LE, Vasilakis C, Jick H. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet 1998; 351(9114): 1467-71.
[http://dx.doi.org/10.1016/S0140-6736(97)11084-4] [PMID: 9605802]
[30]
Pesonen E, Siitonen O. Acute myocardial infarction precipitated by infectious disease. Am Heart J 1981; 101(4): 512-3.
[http://dx.doi.org/10.1016/0002-8703(81)90150-2] [PMID: 7211684]
[31]
Spodick DH, Flessas AP, Johnson MM. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 1984; 53(4): 481-2.
[http://dx.doi.org/10.1016/0002-9149(84)90016-X] [PMID: 6695777]
[32]
Muhlestein JB, Anderson JL, Carlquist JF, et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation 2000; 102(15): 1755-60.
[http://dx.doi.org/10.1161/01.CIR.102.15.1755] [PMID: 11023928]
[33]
O’Connor CM, Dunne MW, Pfeffer MA, et al. Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. JAMA 2003; 290(11): 1459-66.
[http://dx.doi.org/10.1001/jama.290.11.1459] [PMID: 13129985]
[34]
Bovill EG, Bild DE, Heiss G, et al. White blood cell counts in persons aged 65 years or more from the Cardiovascular Health Study. Correlations with baseline clinical and demographic characteristics. Am J Epidemiol 1996; 143(11): 1107-15.
[http://dx.doi.org/10.1093/oxfordjournals.aje.a008687] [PMID: 8633599]
[35]
Suissa S, Assimes T, Brassard P, Ernst P. Inhaled corticosteroid use in asthma and the prevention of myocardial infarction. Am J Med 2003; 115(5): 377-81.
[http://dx.doi.org/10.1016/S0002-9343(03)00393-0] [PMID: 14553873]
[36]
Otto G, Braconier J, Andreasson A, Svanborg C. Interleukin-6 and disease severity in patients with bacteremic and nonbacteremic febrile urinary tract infection. J Infect Dis 1999; 179(1): 172-9.
[http://dx.doi.org/10.1086/314534] [PMID: 9841836]
[37]
Choi HK, Hernán MA, Seeger JD, Robins JM, Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002; 359(9313): 1173-7.
[http://dx.doi.org/10.1016/S0140-6736(02)08213-2] [PMID: 11955534]
[38]
Johnson BW, Goodman CH, Holloway K, de Salazar PM, Valadere AM, Drebot MA. Evaluation of commercially available chikungunya virus immunoglobulin M detection assays. Am J Trop Med Hyg 2016; 95(1): 182-92.
[http://dx.doi.org/10.4269/ajtmh.16-0013] [PMID: 26976887]
[39]
Patel DM, Patel MV, Patel AD, Kaklotar JC, Patel GR, Patel MM. Non-uremic calciphylaxis: a rare and late adverse reaction of warfarin. Curr drug Saf 2019.
[http://dx.doi.org/10.2174/1574886314666190304094407]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 15
ISSUE: 3
Year: 2019
Page: [229 - 233]
Pages: 5
DOI: 10.2174/1573397114666180816112948
Price: $58

Article Metrics

PDF: 27
HTML: 3
EPUB: 1
PRC: 2